At Elixir Pharma, we are proud to collaborate with Aora Health, a Spain-based innovator in nutraceuticals with offices in the UK and a presence in more than 40 countries worldwide.
With GMP-certified facilities and a strong track record in producing high-quality products, Aora Health is recognized for bringing global science closer to everyday wellness.

This collaboration is built on a shared vision between Gonzalo Peñaranda, Co-Founder of Aora Health, and Hany Aly, CEO & Founder of Elixir Pharma — a commitment to improving healthcare outcomes and expanding access to innovative, high-impact treatments throughout North Africa and the wider region.

Together, Elixir and Aora are proud to launch in Egypt, for the very first time, Enzymax — a breakthrough nutraceutical featuring advanced cap-in-cap technology.
This unique delivery system sets a new benchmark in the gastrointestinal market, elevating precision and effectiveness while offering patients a completely new experience in care.
Enzymax is more than a product; it represents how meaningful collaboration can bring cutting-edge innovation directly to those who need it most.

Our partnership with Aora is one rooted in trust, innovation, and the promise of progress.
By combining global expertise with local strength, Elixir and Aora are advancing healthcare together — proving that when collaboration meets innovation, the impact is truly transformative.